CD4 and metabolic dysfunction-associated steatotic liver disease: For example, multiple studies have noted an increase in macrophage or decrease in CD4+ T cell populations in the liver during the development of NAFLD but these studies have not completely determined how these cell populations interact within the liver microenvironment nor have they fully mapped how these populations contribute to disease progression (41–43).